Nine ways to ensure a reliable technology transfer
While these transfers are a normal part of business, navigating them requires a strategic approach to ensure smooth and efficient…
Partner Content
-
-
Peptides in the pipeline: How companies are overcoming the early-stage challenges
Much larger than traditional small molecule drugs, peptides enable rapid tissue penetration while retaining the selectivity and potency of a…
-
How the AI shift is happening now in data management
The newest generation of AI-driven tools is beginning to reshape how clinical databases are built, governed, and maintained. This is…
-
How biopharma is scaling sterile manufacturing in 2026
Aseptic manufacturing plays a crucial role in the pharmaceutical supply chain, ensuring sterility for complex injectable biologics. In recent years,…
-
Extracellular vesicles: The next frontier in regenerative medicine and drug delivery?
Extracellular vesicles (EVs) are tiny, membrane-bound particles released by every cell type studied to date. Though small, they carry a…
-
Navigating uncertainty and building resilient supply chains: The case for US-based CDMO partnerships
Choosing to onshore pharmaceutical manufacturing by partnering with a US-based contract development and manufacturing organization (CDMO) can offer advantages for…
-
Dermatology Trials by the Numbers: Key Trends and Benchmarks for 2026
Dermatology - spanning chronic inflammatory disease, infection, wound healing, pigment disorders, hair loss and rare genetic conditions - is nothing…
-
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…
-
OEB 6: The new standard in high-potent molecule manufacturing?
In recent years, the pharmaceutical industry has seen a significant increase in the development of highly potent active pharmaceutical ingredients…
-
RWD and RWE are rewriting how we design and run trials
Traditional randomized controlled trials (RCTs) have long been the gold standard for testing new therapies, but they are increasingly strained…